Activity of a multitargeted chemo-switch regimen (sorafenib, gemcitabine, and metronomic capecitabine) in metastatic renal-cell carcinoma: a phase 2 study (SOGUG-02-06)-Reference-Cited by-同舟云学术

Activity of a multitargeted chemo-switch regimen (sorafenib, gemcitabine, and metronomic capecitabine) in metastatic renal-cell carcinoma: a phase 2 study (SOGUG-02-06)

Published:2010-04 Issue:4 Volume:11 Page:350-357
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Bellmunt Joaquim,Trigo José Manuel,Calvo Emiliano,Carles Joan,Pérez-Gracia José L,Rubió Jordi,Virizuela Juan Antonio,López Rafael,Lázaro Martín,Albanell Joan

Publisher

Elsevier BV

Subject

Oncology

Reference40 articles.

1. Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling;Wilhelm;Mol Cancer Ther,2008

2. Sorafenib for treatment of renal cell carcinoma: final efficacy and safety results of the phase III treatment approaches in renal cancer global evaluation trial;Escudier;J Clin Oncol,2009

3. The anti-angiogenic basis of metronomic chemotherapy;Kerbel;Nat Rev Cancer,2004

4. Less is more, regularly: metronomic dosing of cytotoxic drugs can target tumor angiogenesis in mice;Hanahan;J Clin Invest,2000

5. Circulating endothelial-cell kinetics and viability predict survival in breast cancer patients receiving metronomic chemotherapy;Mancuso;Blood,2006

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oral tegafur-uracil as a metronomic therapy in stage IVa and IVb cancer of the oral cavity;American Journal of Otolaryngology;2021-11

2. De-escalating cancer treatments during COVID 19 pandemic: Is metronomic chemotherapy a reasonable option?;Critical Reviews in Oncology/Hematology;2021-01

3. Evaluation of oral tegafur‐uracil as metronomic therapy following concurrent chemoradiotherapy in patients with non‐distant metastatic TNM stage IV nasopharyngeal carcinoma;Head & Neck;2019-08-22

4. Metronomic Chemotherapy: A Systematic Review of the Literature and Clinical Experience;Journal of Oncology;2019-03-20

5. Preclinical Organotypic Models for the Assessment of Novel Cancer Therapeutics and Treatment;Current Topics in Microbiology and Immunology;2019